North American Tobacco Distributor Challenges Health Ministry Order

Mar.15.2023
North American Tobacco Distributor Challenges Health Ministry Order
NATC permitted to challenge Health Ministry's "Tobacco Control Law" violation order by Trinidad and Tobago's high court.

North American Trade Company (NATC) has been granted permission by the High Court of Trinidad and Tobago to challenge the Ministry of Health's decision to violate the Tobacco Control Act. The Chief Justice approved NATC's application, allowing the company to continue operations until the matter is resolved.


North American Trading Company (NATC) is an international tobacco distributor.


In November 2022, authorities carried out a raid on NATC, a company located in the Dabadi Free Trade Zone. Accompanying the customs officials and police were representatives of the Tobacco Control Unit (TCU).


Although there was no search warrant, the company permitted officials to enter their warehouse and fully cooperate with the inspection. No illegal items were found during the search process.


On February 9th, 2023, the company received a notice from the TCU stating that they had violated the Tobacco Control Act and must immediately cease operations until obtaining proper licensing.


The NATC maintains that it has not been engaged in the actual sale or distribution of tobacco products in the local market. It believes that the Free Zone is a jurisdiction separate from the Customs Zone, with its own rules for the movement of goods.


In a letter addressed to the Ministry of Health, NATC stated that the order to cease operations has resulted in significant economic losses amounting to $979,714 USD (approximately 6.74 million RMB). This is because the company had to stop obtaining approved exports and instead export from the Duty-Free Zone at the Intercontinental Commerce Park. Ships bound for Trinidad and Tobago were delayed in loading, causing losses and one of their key suppliers requested a suspension on shipping seven containers to NATC due to concerns that they may be prohibited from further export.


A hearing will be held on April 24th regarding this matter.


Reference list:


A distributor plans to challenge a cease-operations order.


A tobacco distributor has been approved to contest the Ministry of Health in court.


This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.

Philip Morris Ukraine Says Ukraine’s Flavored Vape Ban Still Lacks Effective Enforcement
Philip Morris Ukraine Says Ukraine’s Flavored Vape Ban Still Lacks Effective Enforcement
Mikhail Polyakov, deputy general director for corporate affairs at Philip Morris Ukraine, said Ukraine’s ban on flavored and aromatic additives for e-cigarettes, in force since July 11, 2024, has not worked in practice because compliance is not being enforced.
Mar.17 by 2FIRSTS.ai
PMI’s Smoke-Free Business Accounts for 43% of Net Revenues in Q1 as Full-Year EPS Guidance Rises
PMI’s Smoke-Free Business Accounts for 43% of Net Revenues in Q1 as Full-Year EPS Guidance Rises
On April 22, 2026, Philip Morris International released its first-quarter 2026 results. The report showed net revenues of $10.146 billion, up 9.1% year on year; adjusted diluted EPS of $1.96, up 16.0%; and smoke-free products accounting for 43% of total net revenues. Based on first-quarter performance, the company raised its 2026 full-year adjusted diluted EPS forecast to $8.36 to $8.51, or $8.11 to $8.26 excluding currency.
Apr.23 by 2FIRSTS.ai
South Korea Expands Tobacco Harmful Components Testing System to Cover Synthetic Nicotine Liquid Vapes
South Korea Expands Tobacco Harmful Components Testing System to Cover Synthetic Nicotine Liquid Vapes
South Korea’s Ministry of Food and Drug Safety said on April 17 that it has additionally designated the International Characterization Research Institute as a tobacco harmful components testing body under the Act on the Management of Tobacco Harmfulness. The institute has research experience in analyzing harmful components in liquid e-cigarettes and has obtained recognition for tobacco-sector ISO 17025 requirements.
Apr.17 by 2FIRSTS.ai
Indonesian Parliament Reviews Narcotics Law Draft, May Include Vape Ban Proposal
Indonesian Parliament Reviews Narcotics Law Draft, May Include Vape Ban Proposal
According to Beritasatu, Commission III of the Indonesian House of Representatives is reviewing the Draft Law on Narcotics and Psychotropics and considering including a proposal from the National Narcotics Agency (BNN) to ban vapes.
Apr.10 by 2FIRSTS.ai
Exclusive | Shenzhen Tobacco Authorities Ask Licensed Chinese Vape Manufacturers to Submit STN Details for U.S.-Bound Products
Exclusive | Shenzhen Tobacco Authorities Ask Licensed Chinese Vape Manufacturers to Submit STN Details for U.S.-Bound Products
Shenzhen tobacco authorities have asked licensed Chinese vape manufacturers to submit STN details for U.S.-bound products, including CTP Portal or STN email screenshots, highlighting a new compliance signal in cross-border oversight.
Apr.02
Special Report|From Nicotine Pouches to Jelly? A China Tobacco Patent Explores Dual-Release NRT
Special Report|From Nicotine Pouches to Jelly? A China Tobacco Patent Explores Dual-Release NRT
A patent published on February 24, 2026, by China Tobacco Hubei Industrial Co., Ltd. introduces a “nicotine jelly” product designed to combine rapid and sustained nicotine delivery. By integrating both free and microencapsulated nicotine, the product aims to address key limitations of traditional nicotine replacement therapy (NRT), while also raising new regulatory and product classification questions.
Innovation
Mar.18